Discover
ARTV
Artiva Biotherapeutics, Inc.
9.80
2 x 7.02
2 x 12.12
bid
ask
+
0.10
1.03%
2 @ 04:00 PM
10.00 +0.20 (2.04%)
| Ytd | 128.44% | |
| 1y | 540.52% |
9.42
day range
9.94
1.53
52 week range
14.53
| Open | 9.62 | Prev Close | 9.70 | Low | 9.42 | High | 9.94 | Mkt Cap | 476.16M |
| Vol | 364.85K | Avg Vol | 585.19K | EPS | -3.55 | P/E | N/A | Forward P/E | -3.18 |
| Beta | N/A | Short Ratio | 20.47 | Inst. Own | 89.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 9.31 | 200-d Avg | 5.75 | 1yr Est | 21.25 |
ARTV News
benzinga.com
Why Cracker Barrel Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Cracker Barrel (CBRL) stock rises in pre-market trading after reporting better-than-expected Q3 resu
benzinga.com
Needham Reiterates Buy on Artiva Biotherapeutics, Maintains $41 Price Target
Needham analyst Gil Blum reiterates Artiva Biotherapeutics (NASDAQ:ARTV) with a Buy and maintains
benzinga.com
Artiva Biotherapeutics Announces Clinical, Safety And Translational Data For AlloNK, Its Allogeneic,
Multiple EULAR presentations reinforce potential of AlloNK to drive deep B-cell depletion and meanin